Affordable Health Insurance logo Everything You Need to Know About Affordable Health Insurance and More

  The Minority/ Black Health Blog  

Saturday, November 18, 2017

New Digital Pill Can Tell If You've Taken Your Meds

New Digital Pill Can Tell If You've Taken Your Meds
A new digital pill has just been approved by The U.S. Food and Drug Administration (FDA) that is able to track ingestion of medications prescribed for mental illness such as schizophrenia, depression, and bipolar disorder. It allows medical professionals to keep mental illness patients on their treatment.

How it works

The pill contains a sensor that communicates with a wearable patch. The patch sends signals to the patients’ smartphone, telling them whether or not they’ve taken the pill. Physicians can even access the information through a web-based portal. The new digital pill, Abilify MyCite, has been approved for use in patients with schizophrenia, as an add-on treatment for depression, and to help control episodes of manic episodes for people with bipolar disorder.

Economic benefits

Failure to take medications is one of the most serious problems among mental patients. This has cost the United States $100 billion annually, mainly because failure to adhere to treatment leads to sicker patients who often require expensive hospitalization, according to The New York Times.

However, mental illness is considered a stigma among many cultures, such as African Americans, which may contribute to noncompliance with drug treatment. In addition, some may view the new digital pill as an invasion of privacy.

The New York Times also noted that similar digital drugs are being developed for other health conditions, including heart disease, stroke, HIV and diabetes.

For more information about how the pill works, visit
DISCLAIMER: The content or opinions expressed on this web site are not to be interpreted as medical advice. Please consult with your doctor or medical practitioner before utilizing any suggestions on this web site.